Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in Children With Cerebral Malaria
NCT00133393Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxifylline in cerebral malaria (CM), sponsored by National Institute of Allergy and Infectious Diseases. Started Jan 2002; status: terminated.
02
Drugs
pentoxifylline
03
Conditions
cerebral malaria (CM)
Beyond the preview
Go deeper on NCT00133393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133393.